FFTY:ARCA-Innovator IBD 50 Fund (USD)

ETF | Mid-Cap Growth | NYSE Arca

Last Closing

USD 28.13

Change

+0.62 (+2.25)%

Market Cap

USD 0.07B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in companies included in the IBD? 50 Index. The fund will generally hold all of the companies included in the IBD? 50 Index other than during periods when the fund is rebalanced due to changes in the constitution of the IBD? 50 Index. The fund, however, will not invest in the IBD? 50 Index companies in the same proportion as reflected in the index.

Inception Date: 08/04/2015

Primary Benchmark: IBD 50 Index USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.13%

Management Expense Ratio: 0.80 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Mer Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth.. 0.24 %

-0.84 (-0.69%)

USD 15.96B
VOT Vanguard Mid-Cap Growth Index .. 0.07 %

-1.22 (-0.49%)

USD 14.56B
IJK iShares S&P Mid-Cap 400 Growth.. 0.24 %

-0.44 (-0.48%)

USD 9.29B
XMMO Invesco S&P MidCap Momentum ET.. 0.39 %

-0.55 (-0.45%)

USD 2.61B
IVOG Vanguard S&P Mid-Cap 400 Growt.. 0.20 %

-0.64 (-0.56%)

USD 1.09B
ETHO Amplify ETF Trust 0.45 %

+0.01 (+0.02%)

USD 0.18B
CWS AdvisorShares Focused Equity E.. 0.68 %

-0.24 (-0.35%)

USD 0.18B
IPO Renaissance IPO ETF 0.60 %

+0.02 (+0.04%)

USD 0.15B
BFOR Barron's 400 ETF 0.65 %

-0.10 (-0.14%)

USD 0.15B
PEXL Pacer US Export Leaders ETF 0.60 %

-0.12 (-0.24%)

USD 0.06B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.43% 88% B+ 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.43% 88% B+ 83% B
Trailing 12 Months  
Capital Gain 21.83% 31% F 70% C-
Dividend Return 0.68% 33% F 7% C-
Total Return 22.51% 31% F 65% D
Trailing 5 Years  
Capital Gain -15.70% 7% C- 28% F
Dividend Return 2.57% 29% F 8% B-
Total Return -13.13% 7% C- 18% F
Average Annual (5 Year Horizon)  
Capital Gain -2.58% 6% D- 28% F
Dividend Return -1.97% 6% D- 18% F
Total Return 0.61% 56% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 29.30% 19% F 38% F
Risk Adjusted Return -6.73% 6% D- 23% F
Market Capitalization 0.07B 25% F 22% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.